Should grade of tracer uptake on somatostatin receptor-targeted imaging be the major determinant and break the barrier of histopathologic criteria for determining the suitability of Peptide receptor radionuclide therapy?
Radiation Medicine Centre (B.A.R.C) T.M.C Annexe Jerbai Wadia Rd. Parel, Mumbai 400012, India E-mail: drsanb@yahoo.com.
Sandip
S
Basu
D006801:Humans; D007390:International Agencies; D058990:Molecular Targeted Therapy / Q000379:methods*; D018358:Neuroendocrine Tumors / Q000532:radiotherapy*; D009678:Nuclear Energy; D011878:Radiotherapy / Q000379:methods*; D018000:Receptors, Peptide / Q000378:metabolism*; D012958:Societies, Scientific
D018000:Receptors, Peptide